Document is current
Any future updates will be listed below
-
Authors
Salah, Husam M.
Ebner, Adrian
Srinivasa, Ravi N.
Pabon-Ramos, Waleska
Chick, Jeffrey Forris Beecham
Biegus, Jan
Ponikowski, Piotr
Khalifa, Abubaker
Fudim, Marat https://orcid.org/0000-0002-8671-7007
- License Information
-
More Information
Article History
Received: 26 July 2024
Accepted: 13 January 2025
First Online: 3 February 2025
Declarations
:
: Dr. Fudim was supported by the National Heart, Lung, and Blood Institute (NHLBI) (K23HL151744), the American Heart Association (20IPA35310955), Mario Family Award, Duke Chair’s Award, Translating Duke Health Award, Bayer, Bodyport, BTG Specialty Pharmaceuticals and Verily. He receives consulting fees from Abbott, Alleviant, Audicor, AxonTherapies, Bayer, Bodyguide, Bodyport, Boston Scientific, CVRx, Daxor, Deerfield Catalyst, Edwards LifeSciences, Feldschuh Foundation, Fire1, Gradient, Intershunt, NXT Biomedical, Pharmacosmos, PreHealth, Shifamed, Splendo, Vironix, Viscardia, Zoll. Dr. Fudim is an editor in this journal. All other authors declare no disclosures.
